Expressions of AP-1 and TGF-β_1 in renal tissues in diabetic rats and effect of atorvastatin on them
Liling Long
Abstract
Liling Long
Abstract
OBJECTIVE To observe the expressions of AP-1 and TGF-β1 in renal tissues in diabetic rats and the effect of atorvastatin on them. METHODS SD male rats were randomly divided into three groups: normal control group(C),diabetic group(DM), atorvastatin treated group(DA).The expressions of AP-1(c-jun)、TGF-β1 and FN in renal tissues were measured by Immuno-histochemstry. The levels of glucose(Glu) triglyceride(TG),total cholesterol(TC),creatinine(Cr), and 24-hour urine protein excretion were measured by Biochemistry. RESULTS The expressions of AP-1, TGF-β1 and FN in glomeruli increased in the diabetic group and were inhibited by atorvastatin treatment. The levels of 24-hour urine protein(P0.05), TG,TC and Cr decreased in the atorvastatin-treated group (P0.01). The renal histology changes were markedly improved in the atorvastatin-treated group as compared with the diabetic group.CONCLUSION These results suggest that the activated AP-1 plays an important role in the development of diabetic nephropathy. Through inhibition of activation of AP-1, atorvastatin possess therapeutic effects on diabetic nephropathy, independent of its lipid-lowering properties.
A significance statement is not available in the OpenAlex record.
A contribution statement is not available in the OpenAlex record.
Method details are not available in the OpenAlex metadata.
Findings are not separately available in the OpenAlex metadata.
Limitations are not available in the OpenAlex metadata.
Application details are not available in the OpenAlex metadata.
OBJECTIVE To observe the expressions of AP-1 and TGF-β1 in renal tissues in diabetic rats and the effect of atorvastatin on them. METHODS SD male rats were randomly divided into three groups: normal control group(C),diabetic group(DM), atorvastatin treated group(DA).The expressions of AP-1(c-jun)、TGF-β1 and FN in renal tissues were measured by Immuno-histochemstry. The levels of glucose(Glu) triglyceride(TG),total cholesterol(TC),creatinine(Cr), and 24-hour urine protein excretion were measured by Biochemistry. RESULTS The expressions of AP-1, TGF-β1 and FN in glomeruli increased in the diabetic group and were inhibited by atorvastatin treatment. The levels of 24-hour urine protein(P0.05), TG,TC and Cr decreased in the atorvastatin-treated group (P0.01). The renal histology changes were markedly improved in the atorvastatin-treated group as compared with the diabetic group.CONCLUSION These results suggest that the activated AP-1 plays an important role in the development of diabetic nephropathy. Through inhibition of activation of AP-1, atorvastatin possess therapeutic effects on diabetic nephropathy, independent of its lipid-lowering properties.
Key concepts: Atorvastatin, Diabetic nephropathy, Endocrinology, Internal medicine, Creatinine, Triglyceride, Medicine, Diabetes mellitus